PRAX

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Praxis Precision Medicines Inc

NASDAQ | PRAX

162.71

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 16, 2025)

$1.21B

Market Cap

-

P/E Ratio

-12.4

EPS

$91.83

52 Week High

$26.70

52 Week Low

HEALTHCARE

Sector

PRAX Chart

Recent Chart
Price Action

PRAX Technicals

Tags:

PRAX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $8.2M
Total Revenue $8.6M
Cost Of Revenue $358K
Costof Goods And Services Sold $358K
Operating Income -$200M
Selling General And Administrative $56M
Research And Development $152M
Operating Expenses $209M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $358K
Income Before Tax -$183M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$183M
Comprehensive Income Net Of Tax -
Ebit -$200M
Ebitda -$200M
Net Income -$183M

Revenue & Profitability

Earnings Performance

PRAX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $483M
Total Current Assets $404M
Cash And Cash Equivalents At Carrying Value $215M
Cash And Short Term Investments $215M
Inventory -
Current Net Receivables -
Total Non Current Assets $79M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $77M
Short Term Investments $177M
Other Current Assets $12M
Other Non Current Assets -
Total Liabilities $38M
Total Current Liabilities $38M
Current Accounts Payable $13M
Deferred Revenue -
Current Debt -
Short Term Debt $1.3M
Total Non Current Liabilities $110K
Capital Lease Obligations $1.4M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.4M
Other Current Liabilities $24M
Other Non Current Liabilities -
Total Shareholder Equity $445M
Treasury Stock -
Retained Earnings -$837M
Common Stock $14K
Common Stock Shares Outstanding $18M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$132M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $358K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$248M
Cashflow From Financing $514M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$183M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $8.2M
Total Revenue $8.6M
Cost Of Revenue $358K
Costof Goods And Services Sold $358K
Operating Income -$200M
Selling General And Administrative $56M
Research And Development $152M
Operating Expenses $209M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $358K
Income Before Tax -$183M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$183M
Comprehensive Income Net Of Tax -
Ebit -$200M
Ebitda -$200M
Net Income -$183M

PRAX News

PRAX Profile

Praxis Precision Medicines Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to developing innovative therapies for central nervous system disorders linked to neuronal imbalance. Utilizing a proprietary scientific platform, Praxis aims to identify and advance novel treatments for a range of neurological conditions, prioritizing those with significant unmet medical needs. With a strong pipeline and a commitment to enhancing patient outcomes and quality of life, the company is well-positioned to make a meaningful impact in the biopharmaceutical sector.

VHAI
-20.00%
$0.00
VIVK
+4.67%
$0.30
YYAI
-10.71%
$0.12
BURU
+1.07%
$0.34
EPWK
+26.46%
$0.09
NVDA
-0.11%
$179.83
IVF
+85.67%
$1.40
BITF
-18.39%
$5.28
RXRX
-7.21%
$6.29
CGBS
-39.47%
$0.03
PLUG
-8.70%
$3.51
ADAP
+6.57%
$0.19
BYND
-22.39%
$0.52
YDKG
-54.14%
$0.08
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
LAES
-2.09%
$7.49
NIO
-1.09%
$6.74
MIRA
+49.24%
$1.97
SCNX
-20.41%
$0.56
F
-0.27%
$11.72
BBD
+1.71%
$3.25
WHWK
+27.64%
$2.68
ACHR
-8.90%
$11.87
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
KVUE
-13.43%
$14.07
TSLA
-1.47%
$428.75
ONDS
-13.77%
$8.19
IONZ
+18.46%
$3.41
AXDX
-61.36%
$0.03
INTC
-1.10%
$36.74
ETHD
+6.47%
$3.78
DFLI
-32.52%
$1.32
CAN
-14.28%
$1.68
AMD
-1.33%
$235.40
SOFI
-6.13%
$26.31
GDXD
-7.91%
$0.61
RIG
-3.00%
$3.21
MARA
-11.62%
$20.18
CLF
-3.39%
$13.47
GNPX
-43.15%
$0.47
BTG
+3.96%
$5.89
FEMY
+33.89%
$0.73
VSEE
-8.56%
$0.54
BTBT
-8.99%
$3.69
AAL
-6.00%
$11.75
RR
-7.95%
$5.67
GPUS
-6.14%
$0.36
LGCB
+19.39%
$1.97
NAK
-15.71%
$2.22
ABAT
-21.00%
$8.94
QBTS
-10.47%
$40.08
SNAP
-1.83%
$7.76
CIFR
-10.98%
$18.72
CRML
-14.52%
$19.42
QS
-12.89%
$15.54
QSI
-3.23%
$2.54
RF
-5.98%
$23.26
RGTZ
+30.51%
$11.35
UUUU
-12.80%
$21.79
QUBT
-12.12%
$18.65
KEY
-5.35%
$16.78
MASK
+18.73%
$0.57
HBAN
-5.00%
$15.39
IREN
-8.94%
$61.89
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
CLSK
-13.92%
$19.97
SMR
-10.87%
$47.62
T
+0.46%
$26.19
RMBL
+60.50%
$3.21
AAPL
-0.75%
$247.45
GRAB
-3.54%
$5.71
ASST
-11.57%
$0.84
ADD
-25.47%
$0.05
WOK
+3.29%
$0.05
AUUD
+0.97%
$2.06
NOK
+0.53%
$5.68
WULF
-9.53%
$13.99
BAC
-4.03%
$50.17
MU
+4.60%
$200.77
JOBY
-8.66%
$16.07
APLD
-1.69%
$37.11
IONQ
-9.33%
$65.65
NEHC
+9.12%
$3.35
PFE
-0.59%
$24.24
SRM
+53.27%
$10.30
SOND
+78.80%
$1.64
BMNR
-4.90%
$51.16
WTO
-88.69%
$0.13
TOVX
-47.86%
$0.43
KDLY
+1.29%
$0.79
SLNH
-1.39%
$4.23
SATL
-29.71%
$2.91
JBLU
-4.94%
$4.70
AMC
-2.12%
$2.76
AMZN
-0.81%
$213.82
HIMS
-6.07%
$58.94
VHAI
-20.00%
$0.00
VIVK
+4.67%
$0.30
YYAI
-10.71%
$0.12
BURU
+1.07%
$0.34
EPWK
+26.46%
$0.09
NVDA
-0.11%
$179.83
IVF
+85.67%
$1.40
BITF
-18.39%
$5.28
RXRX
-7.21%
$6.29
CGBS
-39.47%
$0.03
PLUG
-8.70%
$3.51
ADAP
+6.57%
$0.19
BYND
-22.39%
$0.52
YDKG
-54.14%
$0.08
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
LAES
-2.09%
$7.49
NIO
-1.09%
$6.74
MIRA
+49.24%
$1.97
SCNX
-20.41%
$0.56
F
-0.27%
$11.72
BBD
+1.71%
$3.25
WHWK
+27.64%
$2.68
ACHR
-8.90%
$11.87
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
KVUE
-13.43%
$14.07
TSLA
-1.47%
$428.75
ONDS
-13.77%
$8.19
IONZ
+18.46%
$3.41
AXDX
-61.36%
$0.03
INTC
-1.10%
$36.74
ETHD
+6.47%
$3.78
DFLI
-32.52%
$1.32
CAN
-14.28%
$1.68
AMD
-1.33%
$235.40
SOFI
-6.13%
$26.31
GDXD
-7.91%
$0.61
RIG
-3.00%
$3.21
MARA
-11.62%
$20.18
CLF
-3.39%
$13.47
GNPX
-43.15%
$0.47
BTG
+3.96%
$5.89
FEMY
+33.89%
$0.73
VSEE
-8.56%
$0.54
BTBT
-8.99%
$3.69
AAL
-6.00%
$11.75
RR
-7.95%
$5.67
GPUS
-6.14%
$0.36
LGCB
+19.39%
$1.97
NAK
-15.71%
$2.22
ABAT
-21.00%
$8.94
QBTS
-10.47%
$40.08
SNAP
-1.83%
$7.76
CIFR
-10.98%
$18.72
CRML
-14.52%
$19.42
QS
-12.89%
$15.54
QSI
-3.23%
$2.54
RF
-5.98%
$23.26
RGTZ
+30.51%
$11.35
UUUU
-12.80%
$21.79
QUBT
-12.12%
$18.65
KEY
-5.35%
$16.78
MASK
+18.73%
$0.57
HBAN
-5.00%
$15.39
IREN
-8.94%
$61.89
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
CLSK
-13.92%
$19.97
SMR
-10.87%
$47.62
T
+0.46%
$26.19
RMBL
+60.50%
$3.21
AAPL
-0.75%
$247.45
GRAB
-3.54%
$5.71
ASST
-11.57%
$0.84
ADD
-25.47%
$0.05
WOK
+3.29%
$0.05
AUUD
+0.97%
$2.06
NOK
+0.53%
$5.68
WULF
-9.53%
$13.99
BAC
-4.03%
$50.17
MU
+4.60%
$200.77
JOBY
-8.66%
$16.07
APLD
-1.69%
$37.11
IONQ
-9.33%
$65.65
NEHC
+9.12%
$3.35
PFE
-0.59%
$24.24
SRM
+53.27%
$10.30
SOND
+78.80%
$1.64
BMNR
-4.90%
$51.16
WTO
-88.69%
$0.13
TOVX
-47.86%
$0.43
KDLY
+1.29%
$0.79
SLNH
-1.39%
$4.23
SATL
-29.71%
$2.91
JBLU
-4.94%
$4.70
AMC
-2.12%
$2.76
AMZN
-0.81%
$213.82
HIMS
-6.07%
$58.94
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.